Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 16;224(9):1599-1604.
doi: 10.1093/infdis/jiab155.

Correlation Between TIGIT Expression on CD8+ T Cells and Higher Cytotoxic Capacity

Affiliations

Correlation Between TIGIT Expression on CD8+ T Cells and Higher Cytotoxic Capacity

Jana Blazkova et al. J Infect Dis. .

Abstract

Persistent exposure to antigen leads to T-cell exhaustion and immunologic dysfunction. We examined the immune exhaustion markers T cell immunoglobulin and ITIM domain (TIGIT) and programmed cell death protein 1 (PD-1) in human immunodeficiency virus (HIV)-infected and healthy individuals and the relationship with cytotoxic CD8+ T-lymphocyte activity. Frequencies of TIGIT but not PD-1 were positively correlated with CD8+ T-lymphocyte activity in HIV-aviremic and healthy individuals; however, there was no correlation in HIV-viremic individuals. Transcriptome analyses revealed up-regulation of genes associated with antiviral immunity in TIGIT+CD8+ versus TIGIT-CD8+ T cells. Our data suggest that TIGIT+CD8+ T cells do not necessarily represent a state of immune exhaustion and maintain an intrinsic cytotoxicity in HIV-infected individuals.

Keywords: TIGIT; cytotoxic T lymphocytes; human immunodeficiency virus; immune exhaustion.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phenotypic and functional analyses of CD8+ T cells expressing markers of immune exhaustion. A, Peripheral blood mononuclear cells of human immunodeficiency virus (HIV)–infected aviremic (n = 81), HIV-infected viremic (n = 42), and healthy individuals (n = 74) were subjected to flow cytometry to determine the levels of T cell immunoglobulin and ITIM domain (TIGIT)+CD8+, programmed cell death protein 1 (PD-1)+CD8+, and TIGIT+PD-1+CD8+ T cells. Black vertical lines represent minimum to maximum data points; black horizontal lines, interquartile range and median values. P values were determined using the Mann-Whitney test. B, Enriched CD8+ T cells of HIV-infected aviremic (n = 61) and viremic (n = 21) and healthy individuals (n = 40) were cocultured with CEM-IIIB cells in the presence of a HIV-specific dual-affinity retargeting (DART) molecule or a control molecule. The cytotoxic activity of CD8+ T cells was determined by the percentage of dead CEM-IIIB cells, using a nucleic acid dye and flow cytometry. The relationship between the CD8+ T-cell–mediated killing and the level of TIGIT+CD8+, PD-1+CD8+, and TIGIT+PD-1+CD8+ T cells is shown for all study groups. Correlations were determined using the Spearman method.
Figure 2.
Figure 2.
Transcriptome analyses of TIGIT+CD8+ and TIGITCD8+ T-cell subsets. Enriched TIGIT+CD8+ and TIGITCD8+ T cells from human immunodeficiency virus (HIV)–aviremic (n = 8), HIV-viremic (n = 6), and healthy individuals (n = 15) were subjected to RNA microarray analysis. A, Principal component analysis. B, Venn diagram of genes differentially expressed in TIGIT+CD8+ versus TIGITCD8+ T cells of the 3 study groups. Numbers of genes commonly expressed among the study groups are indicated. C, Hierarchically clustered heat map of 180 differentially expressed genes between TIGIT+CD8+ and TIGITCD8+ T-cell subsets in HIV-aviremic and healthy individuals. Top categories of gene ontology (GO) analyses are listed. D, Hierarchically clustered heat map of differentially expressed genes in the TIGIT+CD8+ T-cell subsets of HIV-viremic versus HIV-aviremic and healthy individuals. Differences in relative levels of gene expression (z score) are indicated in color, where red indicates up-regulation and blue, down-regulation. Abbreviation: BH, Benjamini-Hochberg; FDR, false discovery rate; ID, identifier.

Similar articles

Cited by

References

    1. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet 2010; 376:49–62. - PubMed
    1. Chun TW, Moir S, Fauci AS. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol 2015; 16:584–9. - PubMed
    1. Sengupta S, Siliciano RF. Targeting the latent reservoir for HIV-1. Immunity 2018; 48:872–95. - PMC - PubMed
    1. Collins DR, Gaiha GD, Walker BD. CD8+ T cells in HIV control, cure and prevention. Nat Rev Immunol 2020; 20:471–82. - PMC - PubMed
    1. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015; 15:486–99. - PMC - PubMed

Publication types

Substances